Pasithea Therapeutics Corp. Share Price
KTTAPasithea Therapeutics Corp. Stock Performance
Open $0.87 | Prev. Close $0.83 | Circuit Range N/A |
Day Range $0.83 - $0.87 | Year Range $0.29 - $3.79 | Volume 724 |
Average Traded $0.84 |
Pasithea Therapeutics Corp. Share Price Chart
About Pasithea Therapeutics Corp.
Pasithea Therapeutics Corp., a clinical-stage biotechnology company, focuses on the discovery, research, and development of treatments for central nervous system (CNS) disorders, RASopathies, and cancers. Its lead product candidate is PAS-004, a next-generation macrocyclic mitogen-activated protein kinase, or MEK inhibitor to treat a range of RASopathies, including neurofibromatosis type 1 (NF1); MAPK pathway-driven tumors, such as BRAFv600 and BRAF fusion tumors; and ETS2 driven diseases, including inflammatory bowel disease (IBD), primary sclerosing cholangitis, and ankylosing spondylitis. The company's lead development candidate is PAS-003, to treat amyotrophic lateral sclerosis. It also intends to develop PAS-001, to treat schizophrenia. Pasithea Therapeutics Corp. was incorporated in 2020 and is headquartered in Miami Beach, Florida.
Pasithea Therapeutics Corp. Historical Data
| Day | Open | Close | Change % |
|---|---|---|---|
26-Feb-26 | $0.87 | $0.83 | +0.00% |
26-Feb-26 | $0.87 | $0.83 | -0.24% |
25-Feb-26 | $0.85 | $0.83 | -2.00% |
24-Feb-26 | $0.83 | $0.85 | +9.23% |
23-Feb-26 | $0.78 | $0.78 | -2.50% |
20-Feb-26 | $0.82 | $0.80 | -0.99% |
19-Feb-26 | $0.73 | $0.81 | +13.80% |
FAQs on Pasithea Therapeutics Corp. Share Price
Can I buy Pasithea Therapeutics Corp. shares in India?
What is the share price of Pasithea Therapeutics Corp.?
What is the 5 year returns of Pasithea Therapeutics Corp.?
What are the high & low stock price of Pasithea Therapeutics Corp. today?
What is the 52-week high and low of Pasithea Therapeutics Corp. stock?